News

The acquisition will be partly funded by the proceeds of Sihuan’s IPO and partly from the company’s internally generated funds. Sihuan has been actively looking for opportunities to

Gerresheimer’s three existing production lines for RTF syringes (Ready-To-Fill syringes) at the Bunde plant (Germany) are now to be supplemented by an additional, latest-generation line. Gerresheimer is now

UBC and CDRD said that the transaction represents the first successful licensing agreement of a technology jointly developed between a UBC researcher and the full drug development platform

The transaction follows Abbott Laboratories global take over of Belgium-based Solvay‘s pharmaceutical business for EUR4.8bn in 2009. Solvay Pharma India has a presence in women’s health, gastroenterology, mental

Immunovaccine’s consolidated net loss was $1,499,000 in Q3 Fiscal 2010, compared to a net loss of $404,000 during the three month period ended September 30, 2009. Of this

Non-silicon electronics, light emitting diodes and pharmaceuticals are said to be the promising areas for bilateral cooperation, FOCUS News Agency reported. The agency quoted Chubais as saying that

Advaxis said that this initiation follows extensive review by the office of the Drugs Controller General of India, a blue ribbon commission of scientists convened to assess Advaxis

Pursuant to such agreement, Nostrum will in-license thrombolytics from IMTECH for clinical development and worldwide commercialisation. Nostrum president Nirmal Mulye said that the new thrombolytics are clot specific

Sun Pharma said that these generic duloxetine hydrochloride delayed-release capsules, 20mg (base), 30mg (base), and 60mg (base) are indicated in the treatment of major depressive disorder (MDD), generalised